Clinical Trial Update: Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials evaluated the safety and efficacy of topiramate for posttraumatic stress disorder; Phase 2 and Phase 3 studies have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University of Oklahoma | Conditions: Posttraumatic Stress Disorder | Phase 2, Phase 3 | Status: COMPLETED